Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Access to green space a mental health lifeline during COVID-19 pandemic, research reveals

  • medicalxpress.com language
  • 2025-08-21 01:00 event
  • 3 days ago schedule
Access to green space a mental health lifeline during COVID-19 pandemic, research reveals
A new national study led by researchers from Carleton University and the University of Toronto reveals that older adults living in greener neighborhoods were less likely to experience depression during the early months of the COVID-19 pandemic.

137. FDA approves sublingual, nonopioid daily treatment for fibromyalgia

  • 3 days ago schedule
  • medicalxpress.com language

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults.

138. Breaking a sweat: Using chloride in sweat to help diagnose cystic fibrosis

  • 3 days ago schedule
  • medicalxpress.com language

Sweat does more than just cool down an overheating body. Measuring the chemical makeup of an individual's sweat—specifically the levels of chloride, a chemical component of salt—can serve as an early warning system to help inform the diagnosis of cystic fibrosis, a genetic disease that damages the lungs and digestive system.

139. Epigenomic landscapes of fat tissue cells reveal how they shape obesity risk

  • 3 days ago schedule
  • medicalxpress.com language

A new study has created the first single-cell map of how DNA is regulated and organized inside different cell-types of human fat tissue. The research shows that many genetic risk factors for abdominal obesity reside in epigenomic regions of fat cells, offering clues about how body fat is genetically and epigenetically regulated and how it might be better controlled. The study, by co-first authors Zeyuan (Johnson) Chen and Sankha Subhra Das, is published in Nature Genetics.

140. FDA approves Wegovy to treat serious liver disease

  • 3 days ago schedule
  • medicalxpress.com language

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious form of fatty liver disease.

141. DNA 'detangler' gene found to prevent deadly blood cell inflammation and cancer

  • 3 days ago schedule
  • medicalxpress.com language

A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that can lead to leukemia, according to findings published in Nature Communications.

142. AI platform uses 3D visualization to reveal disease biomarkers in multiomics data

  • 3 days ago schedule
  • medicalxpress.com language

Researchers say the ability to visualize health data in three dimensions can unlock patterns and relationships among predictive biomarkers that conventional data visualization can't convey. That's why Zeeshan Ahmed and his team at Rutgers developed 3D IntelliGenes, an advanced artificial intelligence and machine-learning platform with the ability to visually analyze multiple types of biological and clinical data—known as multiomics.

143. Dr. Robot will see you now? Medical robots expected to support doctors, not take over patient care

  • 3 days ago schedule
  • medicalxpress.com language

The robot doctor will see you now? Not for the foreseeable future, anyway.

144. Natural molecule discovery could help glaucoma patients

  • 3 days ago schedule
  • medicalxpress.com language

Findings could lead to earlier detection and treatment for those suffering from the serious eye condition.

145. Researchers reverse autism symptoms in mice with epilepsy drugs

  • 3 days ago schedule
  • medicalxpress.com language

Stanford Medicine scientists investigating the neurological underpinnings of autism spectrum disorder have found that hyperactivity in a specific brain region could drive behaviors commonly associated with the disorder.

146. Access to green space a mental health lifeline during COVID-19 pandemic, research reveals

  • 3 days ago schedule
  • medicalxpress.com language

A new national study led by researchers from Carleton University and the University of Toronto reveals that older adults living in greener neighborhoods were less likely to experience depression during the early months of the COVID-19 pandemic.

147. Few depressed teens getting treatment, study finds

  • 3 days ago schedule
  • medicalxpress.com language

Fewer than half of all adolescents with major depressive episode (MDE) received mental health care in the US in 2022, with the odds of specialist treatment being even lower among marginalized groups, according to a study published in the open-access journal PLOS Mental Health by Su Chen Tan and colleagues at University of Tennessee.

148. New drug formulation turns intravenous treatments into a quick injection

  • 3 days ago schedule
  • medicalxpress.com language

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these protein therapeutics require high doses to be effective and are typically formulated at low concentrations to remain stable, IV infusion has been, until now, the only option.

149. Extreme heat poses growing threat to an aging population, but many are unaware of the risk

  • 3 days ago schedule
  • medicalxpress.com language

Older adults often don't realize how vulnerable they are to extreme heat and most aren't prepared for long periods of hot weather, according to a review of more than 40 studies.

150. AI-enhanced ECG can spot patients at risk of dangerous 'heart block' condition

  • 3 days ago schedule
  • medicalxpress.com language

Researchers have developed an AI tool that can help doctors predict who might develop a potentially fatal heart condition, just from an ECG.

151. Promising new treatment using a bacterial virus could combat inherited diseases

  • 3 days ago schedule
  • medicalxpress.com language

An innovative method that uses modified versions of a bacterial virus effective at delivering treatments to human cells shows promise as a more inexpensive and efficient way to treat some deadly genetic diseases.

152. Stapokibart found to be superior to placebo for severe chronic rhinosinusitis with polyps

  • 3 days ago schedule
  • medicalxpress.com language

In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the anti-interleukin 4Rα monoclonal antibody stapokibart improves outcomes, according to a study published online Aug. 18 in the Journal of the American Medical Association.

153. Endometriosis affects more systems in women's bodies than previously understood

  • 3 days ago schedule
  • medicalxpress.com language

In endometriosis, cells similar to uterine tissue grow outside the uterus. According to researchers in the Penn State Department of Kinesiology who study the disease, endometriosis is often treated as a purely gynecological condition. In a new study, however, they demonstrated how the condition, which affects 10% of women around the world, alters how the body responds to feedback.

154. Breastfeeding associated with lower risk of heart issues later in life, study finds

  • 3 days ago schedule
  • medicalxpress.com language

A research team at The Ohio State University Wexner Medical Center and College of Medicine led a study that showed mothers who breastfed their babies, especially those diagnosed with diabetes during pregnancy, have a lower risk of heart issues later in life. The study was recently published in Obstetrics & Gynecology.

155. Immune tolerance observed in iPS cell-derived neural transplants for Parkinson's disease

  • 3 days ago schedule
  • medicalxpress.com language

A research team involved in the recently published successful transplantation of allogeneic iPS cell-derived dopaminergic neural progenitors into patients with Parkinson's disease, led by former Junior Associate Professor Asuka Morizane and Professor Jun Takahashi (Department of Clinical Application), revealed the clinical safety and immune tolerance of the transplanted cells under moderate immunosuppression, regardless of HLA compatibility.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.